• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


111.625 SEK 1.250 1.13%

As of 08:29:03 ET on 04/17/2014.

Snapshot for Meda AB (MEDAA)

Open: 110.250 Day's Range: 110.000 - 112.000 Volume: 0
Previous Close: 110.375 52wk Range: 69.815 - 112.000 1-Yr Rtn: +46.14%

Stock Chart for MEDAA

No chart data available.
  • MEDAA:LI 111.625
  • 1D
  • 1M
  • 1Y
Interactive MEDAA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MEDAA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 10.9727
Relative P/E vs. UKX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 10.1730
Est. PEG Ratio 0.5553
Market Cap (M SEK) 33,737.88
Shares Outstanding (M) 302.24
30 Day Average Volume 10,320
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.24%
Cash Dividend (SEK) 2.5000
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MEDAA

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MEDAA

Meda AB is a specialty pharmaceutical company. The Company imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. Meda's products are sold in the Nordic countries and in the Baltic states on behalf of foreign manufacturers. The Company markets to wholesale dealers and hospitals.

Bert-Ake ErikssonChairmanJoerg-Thomas DierksChief Executive Officer
Henrik StenqvistChief Financial OfficerRichard SpiveyChief Scientific Officer
More Company Profile & Key Executives for MEDAA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil